MT-TF

gene
On this page

Also known as trnF

Summary

MT-TF (mitochondrially encoded tRNA-Phe (UUU/C), HGNC:7481) is a mitochondrial tRNA gene on chromosome mitochondria.

Predicted to enable triplet codon-amino acid adaptor activity. Predicted to be involved in translation.

Source: NCBI Gene 4558 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (Mt_tRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:7481
Approved symbolMT-TF
Namemitochondrially encoded tRNA-Phe (UUU/C)
Locationmitochondria
Locus typeRNA, transfer
StatusApproved
AliasestrnF
Ensembl geneENSG00000210049
Ensembl biotypeMt_tRNA
OMIM590070
Entrez4558
RNAcentralURS00003E8921 — tRNA, 71 nt, 5 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 Mt_tRNA

ENST00000387314

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000387314 — 1 exons

ExonStartEnd
ENSE00001544501577647

Expression profiles

Bgee: expression breadth ubiquitous, 118 present calls, max score 99.72.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 418.5871 / max 21897.5002, expressed in 1827 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
194814398.42521827
19481520.16191696

Top tissues by expression

118 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
prefrontal cortexUBERON:000045199.72gold quality
amygdalaUBERON:000187699.65gold quality
skeletal muscle tissueUBERON:000113499.62gold quality
putamenUBERON:000187499.54gold quality
caudate nucleusUBERON:000187399.53gold quality
nucleus accumbensUBERON:000188299.53gold quality
substantia nigraUBERON:000203899.52gold quality
Ammon’s hornUBERON:000195499.49gold quality
frontal cortexUBERON:000187099.44gold quality
right frontal lobeUBERON:000281099.41gold quality
anterior cingulate cortexUBERON:000983599.29gold quality
hypothalamusUBERON:000189899.27gold quality
sural nerveUBERON:001548899.17gold quality
apex of heartUBERON:000209899.00gold quality
adult mammalian kidneyUBERON:000008298.97gold quality
duodenumUBERON:000211498.90gold quality
C1 segment of cervical spinal cordUBERON:000646998.46gold quality
mucosa of stomachUBERON:000119998.41gold quality
cerebral cortexUBERON:000095698.23gold quality
kidneyUBERON:000211398.18gold quality
right hemisphere of cerebellumUBERON:001489097.77gold quality
cerebellar hemisphereUBERON:000224597.54gold quality
granulocyteCL:000009497.50gold quality
heart left ventricleUBERON:000208497.29gold quality
brainUBERON:000095597.14gold quality
olfactory segment of nasal mucosaUBERON:000538696.91gold quality
metanephros cortexUBERON:001053396.48gold quality
dorsolateral prefrontal cortexUBERON:000983496.25gold quality
rectumUBERON:000105295.86gold quality
adrenal tissueUBERON:001830395.65gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.41

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 4)

  • We report a novel heteroplasmic T–>C mutation at nt position 582 within the mitochondrial tRNA(Phe) gene of a 70-year-old woman with mitochondrial myopathy; This adds to the previously described four pathogenic mutations in the tRNA(Phe) gene (PMID:14659412)
  • role of the point mutation at position 616 in the MT-TF gene (T>C or T>G)in severe epilepsy (PMID:20142618)
  • Optic neuropathy, cardiomyopathy, and cognitive disability was found in patients with a homozygous mutation in the nuclear MTO1 and a mitochondrial MT-TF variant. (PMID:26061759)
  • This is the 18th MT-TF point mutation associated with a mitochondrial disorder. The onset and the severity of the disease, however, is unique in this case and broadens the clinical picture related to mutations of mitochondrial tRNA-Phe. (PMID:31009750)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.